[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "UK Pandemic Update", "description": "UK\n\u2018Leaked\u2019 SAGE worst case, UK, 85,000 deaths over the winter\n\nhttps://www.bbc.co.uk/news/uk-53954492\n\nmid-October, there were between 43,000 and 74,000 new infections per day\n\nConsensus statement from the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O) for the Scientific Advisory Group for Emergencies (SAGE). (14th October)\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/931162/S0808_SAGE62_201014_SPI-M-O_Consensus_Statement.pdf\n\nR = 1.3 and 1.5\n\nIn England, we are breaching the number of infections and hospital admissions in the Reasonable Worst Case planning scenario\n\nand is almost certain to exceed this within the next two weeks\n\nhttps://coronavirus.data.gov.uk/cases\n\n\nUK\n\nTier 4 restrictions\n\nONS (30th October)\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26\n\nInfection survey, 17 to 23 October 2020\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest\n\nUK number of infections continues to increase\n\nEngland\n\nPrevalence, 568,100\n\nAbout 1 in 100 people\n\n9.52 new COVID-19 infections for every 10,000 people\n\nIncreases in all age groups over the past two weeks\n\nOlder teenagers and young adults, highest current rates\n\nRates appear to be steeply increasing secondary school age\n\nNorth West, Yorkshire, Humber\n\nNorth East, levelled off now\n\n51,900 new cases per day\n\nWales\n\nPrevalence, 26,100\n\nOne in 120 people\n\nNorthern Ireland \n\nPrevalence, 24,300 \n\nOne in 150\n\nScotland\n\nPrevalence, 37,400\n\nPositivity rate 0.71% \n\nOne in 140 people \n\nUK total prevalence, 655,900\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nDeaths, 9 \u2013 16 October (week 42) England and Wales\n\nDeaths registered was 10,534\n\nUp 580 from week 41\n\n6.8% (669 deaths higher) than five-year average\n\nThe number would have to get to 1,200 deaths above the norm to be classified as \"excess\" above random expected variations\n\n670 certificates mentioned coronavirus representing 6.4% of all deaths\n\nAn increase of 232 deaths compared with Week 41, (438 deaths or 4.4% of all deaths)\n\nThe numbers of deaths in hospitals remained below the five-year average\n\nDeaths involving COVID-19 in hospitals, 8.4% of all hospitalised deaths\n\nPatients currently hospitalised with COVID\n\nhttps://coronavirus.data.gov.uk/cases", "link": "https://www.youtube.com/watch?v=qtDMzpIJp58", "date_published": "2020-10-31 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US Pandemic Update", "description": "United States\n\nhttps://www.cdc.gov/flu/weekly/index.htm\n\nCDC\n\nPneumonia, Influenza, COVID-19 (PIC)\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcovid-data%2Fcovidview.html\n\nPositive tests\n\nWeek 42, (ending 17th October), 6.6%\n\nWeek 43 (ending 24th October), 7.1%\n\nPercent positivity increased among all age groups\n\nand in all 10 Department of Health and Human Services (HHS) regions\n\nHospitalisations\n\nSince week ending September 26 (week 39), weekly hospitalization rates have increased\n\nIncrease in rates among adults aged 18 years and older\n\nhttps://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html\n\nThe age-adjusted hospitalization rate\n\nHispanic or Latino, 4.4 times that of non-Hispanic White\n\nAmerican Indian or Alaska Native, 4.3 times non-Hispanic white people\n\nNon-Hispanic black, 4.3 times\n\nDeaths\n\nThe percentage PIC deaths, flat from mid-September through mid-October\n\nDeath certificate data, the percentage of deaths attributed to PIC for week 43 was 8.2%\n\nDeclining, but above the epidemic threshold.\n\nhttps://covid.cdc.gov/covid-data-tracker/#cases_casesinlast7days\n\nPoland\n\nCases, + 21,629\n\nPeople over 70 should stay at home for the next two weeks, (Prime Minister Mateusz Morawecki)", "link": "https://www.youtube.com/watch?v=Ns0zIhnD0Ts", "date_published": "2020-10-31 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Winter Vitamin D Update", "description": "Vitamin D\nEssential role in immunomodulation\nInnate and adaptive immune systems\nEnhances innate immunity, immune peptides, anti-viral effects, disrupt viral envelopes\nSuppressing the excessive expression of proinflammatory cytokines\nRegulating the expression of ACE2 receptors\nEpidemiological and clinical evidence, incidence, severity and mortality\nLow levels \nHypertension, diabetes, cancer, cardiovascular diseases\n\nEffect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study\n\nhttps://covid19.tabipacademy.com/2020/09/08/vitamin-d-reduces-risk-of-icu-admission-97/\n\nhttps://www.sciencedirect.com/science/article/pii/S0960076020302764?via%3Dihub\n\n50 patients treated with calcifediol\n\nOne required admission to the ICU (2%)\n\nNo deaths\n\nAll discharged, without complications\n\n26 untreated patients\n\n13 required ICU (50 %)\n\n2 died\n\nCalcifediol clinical trial, 1,000 patients, 15 hospitals\n\nhttps://sevilla.abc.es/andalucia/cordoba/sevi-coronavirus-cordoba-calcifediol-ensayo-clinico-1000-pacientes-15-hospitales-probara-eficacia-farmaco-contra-covid-202010091322_noticia.html?ref=https:%2F%2Fwww.youtube.com\n\nVitamin D Status in Hospitalized Patients With SARS-CoV-2 Infection \n\nThe Journal of Clinical Endocrinology & Metabolism (Accepted, 27th October 2020)\n\nhttps://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgaa733/5934827\n\nTo assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with COVID-19\n\nAnalyze the possible influence of vitamin D status on disease severity\n\nRetrospective\n\nCase-control\n\n216 COVID-19 patients\n\n197 population-based controls\n\nResults\n\nVitamin D deficiency was defined as serum 25OHD levels  less than 20 ng/ml (50 nmol/L) \n\nCOVID patients group\n\nMean levels 13.8  ng/ml. (34.5 nmol/L)\n\n82.2% vitamin D deficient \n\nCommunity control group\n\nMean levels 20.9 ng/ml (52.25 nmol/L) (p less than 0.0001)\n\n47.2% vitamin D deficient\n\nBlood levels lower in men than in women\n\n\nEvidence of protective role of Ultraviolet-B (UVB) radiation in reducing COVID-19 deaths (Nature scientific reports, 19th October 2020)\n\nhttps://www.nature.com/articles/s41598-020-74825-z\n\nUltraviolet-B (UVB) radiation, mediated by vitamin D synthesis\n\nDataset of 152 countries over 108 days (n\u2009=\u20096,524)\n\nA permanent unit increase in UVI is associated with a 1.2 percentage points decline in daily growth rates of cumulative COVID-19 deaths\n\nand a 1.0 percentage points decline in the CFR daily growth rate\n\nGlobally\nMinus 12% of cumulative COVID-19 deaths\n\nMinus 38% on CFR\n\nWe find a significant negative association between UVI and COVID-19 deaths\n\nindicating evidence of the protective role of UVB in mitigating COVID-19 deaths\n\nIf confirmed via clinical studies, then the possibility of mitigating COVID-19 deaths via sensible sunlight exposure or vitamin D intervention would be very attractive\n\n\nVitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection\n\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799\n\nAssociation between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes\n\nn = 235\n\nResults\n\nBased on CDC criteria, among our study patients, 74% had severe COVID-19 infection and 32.8% were vitamin D sufficient. \n\nVitamin D sufficiency\n\n25(OH)D less than 30 ng/ml.  (75 nmol/L)\n\nReduction in clinical severity\n\nInpatient mortality\n\nSerum levels of C-reactive protein (CRP)\n\nIncrease in lymphocyte percentage\n\nVitamin D insufficiency in southern Arizona (American Journal of Clinical Nutrition)\n\nhttps://academic.oup.com/ajcn/article/87/3/608/4633323\n\nPopulation 26.1 ng/ml  (65.25 nmol/L)\n\nBelow 20 ng/ml  (50 nmol/L)\n\nBlacks 55%\n\nHispanics 37.6%\n\nWhites 22.7% \n\nAlso more obesity in first two groups\n\nAdult Health Status Among Native American Families Participating in the Growing Resilience Home Garden Study (CDC August 22, 2019)\n\nhttps://www.cdc.gov/pcd/issues/2019/19_0021.htm\n\nNorthern Arapaho and Eastern Shoshone tribes sharing the Wind River Indian Reservation (WRIR) in Wyoming reportedly die 30 years earlier than whites in the state\n\nNearly 80% of adults had deficient vitamin D levels ( less than 20 ng/mL; n = 167) (50 nmol/L)\n\nObesity \n\nWaist circumference, associated with higher risk of obesity-related disease\n\nWomen 95%\n\nMen 80%\n\nHypertension\n\nDiabetes\n\nEVMS CRITICAL CARE COVID-19 MANAGEMENT PROTOCOL \n\nhttps://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf\n\nIf you would like to donate to John's educational projects, please use the following link, thank you, https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=78GGHGLK5ZXAE", "link": "https://www.youtube.com/watch?v=HxtddpoPMKo", "date_published": "2020-10-31 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]